ClinVar Miner

Submissions for variant NM_000199.5(SGSH):c.1105G>A (p.Glu369Lys) (rs104894640)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
EGL Genetic Diagnostics, Eurofins Clinical Diagnostics RCV000078349 SCV000232480 pathogenic not provided 2013-08-06 criteria provided, single submitter clinical testing
GeneDx RCV000078349 SCV000582578 pathogenic not provided 2015-09-03 criteria provided, single submitter clinical testing The E369K variant in the SGSH gene has been reported previously in association with mucopolysaccharidosis IIIA (MPS IIIA) (Di Natale et al., 1998; Weber et al., 1997). Two individuals who were compound heterozygous for E369K and a different variant were reported to have a mild-intermediate phenotype (Di Natale et al., 1998; Esposito et al., 2000). In comparison with the wild type, E369K yielded similar molecular size and stability on western blot with the authors predicting the variant does not cause a dramatic change to the protein structure and function (Esposito et al., 2000). Therefore, we interpret E369K as a pathogenic variant.
Counsyl RCV000005424 SCV000790783 likely pathogenic Mucopolysaccharidosis, MPS-III-A 2017-05-02 criteria provided, single submitter clinical testing
OMIM RCV000005424 SCV000025606 pathogenic Mucopolysaccharidosis, MPS-III-A 2003-04-01 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.